Investors on Wall Street shrugged off the $51 million hit to C.R. Bard’s (NYSE:BCR) bottom line from a legal settlement, bumping shares up about 2% today.
Danaher Corp.
Baxter boosts forecast after strong Q3 | Earnings Roundup
Baxter International Inc. (NYSE:BAX) said it now expects to post earnings of at least $4.29 per share this year, after logging strong third-quarter results.
Infuse lawsuits pile up for Medtronic | Legal News
Personal injury lawsuits over its controversial Infuse bone-growth protein are beginning to pile up for Medtronic Inc. (NYSE:MDT), after the Spine Journal revealed serious concerns about the device’s safety this summer.
Warning letter: FDA unleashes laundry list of accusations against Beckman Coulter
The FDA filed a Warning Letter against Beckman Coulter Inc. (NYSE:BEC) this month, detailing a long list of alleged quality issues surrounding the company’s manufacturing facility.
Based on an investigation of Beckman’s Brea, Calif.-based facility, the watchdog agency found problems with design validation processes, design change processing procedures, personnel training and reporting and execution systems for corrective and preventative actions, among other complaints.
Recall: FDA hits Beckman Coulter’s Synchron flow cell with Class I recall
The FDA put a Class I recall on Beckman Coulter Inc.’s (NYSE:BEC) Synchron clinical chemistry analyzer.
The device is a computer-controlled clinical analyzer for determining chemistries in various fluids including blood, urine and cerebrospinal fluid.
Wright Medical CEO and CTO out
Wright Medical Group Inc. (NSDQ:WMGI) announced a surprise shakeup of its executive team today, firing its chief technology officer and accepting the resignation of CEO Gary Henley.
The Arlington, Tenn.-based maker of orthopedic devices for the foot and ankle market said in a regulatory filing that Henley resigned prior to a board meeting yesterday.
Legal roundup: Siemens ups the ante in Saint-Gobain suit
PerkinElmer says “No sale”
PerkinElmer Inc. (NYSE:PKI) shares are now down more than 4 percent today, falling $1.12 to $26.60 after the diagnostics giant flatly denied takeover speculation.
Thoratec scuttles ITC deal with Danaher
Another deal went south for Thoratec Corp. (NSDQ:THOR), this time over concerns with its International Technidyne Corp. division’s regulatory and quality systems and the failure of a key product to win a green light from the Food & Drug Administration.
The Pleasanton, Calif.-based cardiac assist device maker scuttled its deal with Danaher Corp. (NYSE:DHR) for a $110 million buyout of ITC, saying the parties couldn’t agree on "the status of certain aspects of ITC’s quality system and regulatory filings," according to a press release.
FTC forces sale of MDS lasers business after Danaher buyout
The Federal Trade Commission will force the sale of MDS Inc.’s (NYSE:MDZ) laser-microdissection unit to Life Technologies Corp. (NSDQ:LIFE) after Danaher Corp. (NYSE:DHR) completes its $650 million buyout of MDS.
The anti-trust watchdog wants to make sure that two of the four North American suppliers of the devices don’t wind up under the same corporate roof, according to Dow Jones Newswires.
UPDATE: PerkinElmer settles lawsuits with one-time partner
PerkinElmer and a long-time joint venture partner have resolved all of their legal battles, with PerkinElmer agreeing to drop a patent-infringement suit as part of a broader deal clearing the way for MDS Inc. to sell a division producing plasma mass spectrometers to a third company.
Waltham, Mass.-based PerkinElmer (NYSE:PKI) last month sued MDS (NYSE:MDZ) after the Toronto-area company announced plans in September to sell its Analytical Technologies division to Danaher Corp. (NYSE:DHR) for $650 million. PerkinElmer and MDS began their collaboration in 2001 to develop so-called “time-of-flight” mass spectrometers.